0
0We live in an era of "Promise Overload." Whether it's a quantum computing unicorn valued at 7 billion or humanoid robots promising mass delivery by 2026, tech companies are handing us checks written for the "future." But what is the cost when these promises face delays?
In this episode, we dive deep into the tension between technological hype and commercial reality. We contrast two survival logics: the "moonshot" approach of hard tech versus the pragmatic, cash-flow-first approach of medical AI. As the market begins to levy a heavy "Trust Tax" on undelivered promises, how should founders and investors navigate the game between "long-term storytelling" and "instant gratification"?
